Immunology of early pregnancy loss

Contemporary Ob-Gyn

Volumn 43, Issue 6, 1998, Pages 40-56

  Scott, James R ^a   Branch, Ware ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 11544276632     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Scott JR, Branch OW. Potential alloimmune factors and immunotherapy in recurrent miscarriage. Clin Obstet Gynecol. 1994;37:761-774.
2. Byrne JL, Ward K. Genetic factors in recurrent abortion. Clin Obstet Gynecol. 1994;37:693-704.
3. Early pregnancy loss. ACOG Technical Bulletin. 1995;212:1-7.
4. Scott JR. Recurrent abortion. Clin Obstet Gynecol. 1994;37:623-673.
5. Scott JR, Branch DW. Evaluation and treatment of recurrent miscarriages. In: Keye WR, Cnang RJ, Rebar RW, et al, eds. Infertility: Evaluation and Treatment. Phil, Pa: WB Saunders Co; 1995:230-248.
6. van Leeuwen I, Branch DW, Scott JR. First-trimester ultrasound findings in women with a history of recurrent pregnancy loss. Am J Obstet Gynecol. 1993;168:111-114.
7. Hill JA. Immunotherapy for recurrent pregnancy loss: standard of care or buyer beware. J Soc Gynecol Invest. 1997;4:267-273.
8. Wallace DJ, Druzin ML, Lahita RG. Clinical rheumatologic applications of reproductive immunology: facts, fiction and fancy. Arthritis Rheum. 1997;40:209-215.
9. Kutteh WH, Stovall DW, Scott JR. The immunologic diagnosis and treatment of recurrent pregnancy loss. Infertil Reprod Med Clin NA. 1997;8:267-287.
10. Beer AE, Kwak JYH, Gilman-Sachs A, et al. New horizons in the evaluation and treatment of recurrent pregnancy loss. In: Hunt JS, ed. Immunobiology of Reproduction. New York, NY: Springer-Verlag; 1994:316-344.
11. Sher G, Feinman M, Zouves C, et al. High fecundity rates following antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod. 1994;9:2278-2283.
12. Hatasaka HH, Branch DW, Kutteh WH, et al. Autoantibody screening for infertility explaining the unexplained. J Peprod Immunol. 1997;34:137-153.
13. Cowchock FS, Reece EA, Balaban D, et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone to low-dose heparin treatment. Am J Obstet Gynecol. 1992;166:1318-1323.
14. Branch DW, Silver RM, Blackwell JL, et al. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol. 1992;80:614-620.
15. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996;174:1584-1589.
16. Rai R, Cohen H, Dave M, et al. Randomized controlled trial of aspirin and aspirin plus heparin in pregnancy in women with recurrent miscarriage associated with phospholipid antibodies. BMJ. 1997;314:253-257.
17. Spinnato JA, Clark AL, Pierangeli SS, et al. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol. 1995;172:690-694.
18. Coulam CB, Clark DA, Collins J, Scott JR. Worldwide collaborative observational study and meta-analysis on allogeneic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol. 1994;32:55-72.
19. Daya S, Gunby J. The recurrent miscarriage immunotherapy trialist group. The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent spontaneous abortion. Am J Reprod Immunol. 1994;32:294-302.
20. Jeng GT, Scott JR, Burmeister LF. A comparison of meta-analytic results using literature vs. individual patient data: paternal cell immunization for recurrent miscarriage. JAMA. 1995;274:830-834.
21. Scott JR. Immunotherapy for recurrent miscarriage. The Cochrane Library. 1997;3:1-10.
22. Mueller-Eckhardt 6 (The German RSA/IVIG Group). Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br J Obstet Gynaecol. 1994;101:1072-1077.
23. Coulam CB, Krysa L, Stern J, et al. Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol. 1995;34:333-337.
24. Christiansen OB, Mathiesen O, Husth M, et al. Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with IV immunoglobulin. Hum Reprod. 1995;10:2690-2695.
25. Stephenson MD, Dreher K, Houlihan E, et al. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo controlled trial. Am J Reprod Immunol. 1998;39:82-88.
26. Sueoka K, Shiokawa S, Miyazaki T, et al. Integrins and reproductive physiology: expression and modulation in fertilization, embryogenesis, and implantation. Fertil Steril. 1997;67:799-811.
27. Rote NS. Antiphospholipid antibodies and recurrent pregnancy loss. Am J Peprod Immunol. 1996;35:394-401.
28. Rand JH, Wu X, Andree HAM, et al. Pregnancy loss in the antiphospholipid syndrome - a possible thrombogenic mechanism. N Engl J Med. 1997;337:154-160.
29. Daya S. Efficiency of progesterone support for pregnancy in women with recurrent miscarriage. A metaanalysis of controlled trials. Br J Obstet Gynaecol. 1992;167:275-280.